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The incidence and transmission patterns of extended-spectrum-b-lactamase (ESBL)-producing Klebsiella
pneumoniae in patients admitted to the intensive care unit (ICU) of a university hospital were investigated over
a 3-year period. K. pneumoniae isolates were characterized by antibiotic susceptibility, capsular serotyping,
plasmid profiles, and pulsed-field gel electrophoresis (PFGE) of genome macrorestriction patterns with XbaI,
and the results were compared with those obtained by typing with the randomly amplified polymorphic DNA
(RAPD) patterns. The discriminatory power of RAPD typing was evaluated for three primers. The incidence of
isolation of ESBL-producing K. pneumoniae was 2.5 cases per 1,000 admissions to the ICU versus 0.35 cases per
1,000 admissions to other units (relative risk, 7.03; 95% confidence interval, 3.89 to 12.69). Infection developed
in 53% of evaluable patients. Thirty-six percent of the cases were possibly acquired in other institutions.
Isolates from ICU patients were subdivided into six capsular serotypes and into four clonal groups based on
antibiotype, plasmid content, and PFGE and RAPD patterns. Two clones were associated with clusters of
cross-infection, involving 5 and 12 patients, respectively. Following implementation of contact isolation pre-
cautions, the incidence of nosocomial acquisition of ESBL-producing K. pneumoniae decreased from 0.55 to
0.26 cases per 1,000 admissions (P 5 0.03). PFGE and RAPD analysis showed concordant results and
comparable discrimination for differentiation between groups of epidemiologically related strains of ESBL-
producing K. pneumoniae. More subclonal variants were determined among epidemic clones by PFGE analysis
than by RAPD analysis. Both methods are useful for typing K. pneumoniae strains in epidemiological investi-
gations, although RAPD analysis is more efficient.
Resistance to broad-spectrum cephalosporins has emerged
in strains of members of the family Enterobacteriaceae follow-
ing frequent use of these drugs in the hospital setting (13, 18).
Endemic and epidemic nosocomial infections caused by ex-
tended-spectrum-b-lactamase (ESBL)-producing Klebsiella
pneumoniae cells represent a persistent problem in many parts
of the world, especially in intensive care units (ICU) (2, 4, 5,
12, 17–19). Epidemic strains of cephalosporin-resistant K.
pneumoniae have been associated with increased morbidity
and mortality in hospitalized patients (7, 18). Since 1983, nos-
ocomial outbreaks of ESBL-producing K. pneumoniae infec-
tions in Europe, the United States, and South America were
described (12, 13). More than 30 plasmid-mediated ESBLs in
various species of Enterobacteriaceae have been characterized
(12). In France, 10 to 30% of K. pneumoniae strains are re-
ported to produce plasmid-mediated ESBL of the TEM or
SHV families (12).
Understanding the epidemiology of ESBL-producing K.
pneumoniae requires the use of accurate epidemiological
markers able to differentiate between the spread of resistance
plasmids and strain dissemination. Initially, K. pneumoniae
strains were characterized by capsular serotyping and plasmid
analysis (2, 21, 23). Subsequently, pulsed-field gel electro-
phoresis (PFGE) analysis of genome macrorestriction frag-
ments was shown to be a more discriminating typing technique
(1, 22). However, PFGE is a technically demanding and time-
consuming technique that requires specific equipment. PCR-
based typing techniques, such as randomly amplified polymor-
phic DNA (RAPD) analysis, are faster and easier to perform
(24). In recent studies, RAPD analysis has been successfully
used to type a diversity of microorganisms (2, 10, 15–17, 24).
The aims of the present study were to determine the inci-
dence and origin of acquisition of ESBL-producing K. pneu-
moniae strains isolated from ICU patients admitted to a Bel-
gian university hospital and to delineate the clonal diversity
and transmission patterns of these strains by comparing results
of capsular serotyping, plasmid profile, genome macrorestric-
tion analysis (PFGE), and RAPD patterns. The respective
values of the latter two genomic typing methods for epidemi-
ologic typing of K. pneumoniae were evaluated in more detail.
(This work was presented in part at the 32nd Interscience
Conference on Antimicrobial Agents and Chemotherapy,
Anaheim, Calif., 11 to 14 October 1992.)
MATERIALS AND METHODS
Epidemiological investigation. Erasme hospital is a 900-bed university hospital
that admits approximately 27,000 patients annually. In four adult ICU with a
total of 30 beds, 240 patients are admitted monthly. The hospital antibiotic policy
is based on a drug formulary, written local guidelines for empiric and docu-
mented therapy, and daily consultancy with infectious disease specialists and
clinical microbiologists for management of serious infections and use of reserved
drugs, including extended-spectrum cephalosporins.
During the period from January 1990 to December 1992, patients with K.
pneumoniae isolates resistant to extended-spectrum cephalosporins were identi-
fied by a daily computer search in the microbiology database and were investi-
gated clinically. Resistant isolates were stored by freezing at 2708C. A cluster of
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cases was defined as two or more cases of resistant K. pneumoniae isolation
among patients who stayed at the same time in the same unit of the hospital.
To prevent nosocomial transmission of ESBL-producing K. pneumoniae
strains, colonized patients were placed in contact isolation starting in January
1991. Precautions include patient admission to a single room and use of gloves
and aprons for all patient care procedures, which were followed by alcohol-based
disinfection of hands.
Antimicrobial susceptibility. Susceptibility to antimicrobial agents was tested
by the disk diffusion method on Mueller-Hinton agar (Biome´rieux, Marcy
l’Etoile, France) as described in the recommendations of the Comite´ de
l’Antibiogramme de la Socie´te´ Francaise de Microbiologie. The production of
clavulanic acid-susceptible ESBL was detected by using the double-disk synergy
test as described by Jarlier et al. (13). Additionally, inhibition zone diameters of
various b-lactams, including aztreonam and imipenem, aminoglycosides, chlor-
amphenicol, and other antibiotics, were measured. The MICs of ceftazidime and
ceftriaxone were determined by using the E-test method (AB Biodisk, Solna,
Sweden) on Mueller-Hinton agar, with and without clavulanic acid (4 mg/ml)
added in agar, for quantification of inhibition of b-lactamase activity.
Capsular serotyping. The capsular (K) antigen was determined by counter-
current immunoelectrophoresis at the Laboratory for Hospital Infections of the
Public Health Laboratory Service, Colindale, London, United Kingdom (24).
Plasmid profile analysis. Plasmid DNA was extracted by a rapid procedure
described previously. (22). Plasmid DNA was analysed by electrophoresis in 1%
agarose gels at 50 V for 15 h in 13 TBE buffer (40 mM Tris base, 40 mM boric
acid, 1 mM EDTA). The gels were stained with ethidium bromide and were
photographed under UV light. The sizes of plasmids were determined by com-
paring their distances of migration with those of plasmids of known size from
strains Escherichia coli 39R861 and V517 (National Collection of Type Cultures,
London, United Kingdom) and of the supercoiled DNA ladder (Gibco-BRL,
Ghent, Belgium).
Genome macrorestriction analysis by PFGE. Macrorestriction of bacterial
genomic DNA was obtained by using XbaI. PFGE separation was performed
with a contour-clamped homogeneous electric field Mapper II system (Bio-Rad,
Nazareth, Belgium) as previously described (22). A SmaI chromosomal digest of
Staphylococcus aureus NCTC 8325 was used as a molecular size marker. Patterns
were visually compared by two independent observers blinded to strain origin
and were classified into major types (clonal group) and subtypes (clonal variants)
according to previously described criteria (22).
RAPD analysis. Bacteria were grown overnight on Columbia agar medium
supplemented with 5% sheep blood. A colony was suspended in 0.5 ml of lysis
buffer (20 mM Tris-HCl [pH 8.3] at 208C, 50 mM KCl, 0.1% Tween 20) heated
at 968C for 10 min and then maintained at room temperature until used in the
reaction mixture. The following three primers were used: AP4 (59-TCACGAT
GCA-39) (26), HLWL74 (59-ACGTATCTGC-39) (17), and R108 (59-GTATTG
CCCT-39) (3) (Genset, Paris, France). The reaction mixture contained 10 mM
Tris-HCl (pH 8.3), 50 mM KCl, 2.5 mMMgCl2, 4 mM each primer, 400 mM each
deoxynucleoside triphosphate, 0.5 U of Taq DNA polymerase (Perkin-Elmer
Cetus, St. Quentin en Yvelines, France), and 1 ml of extract in lysis buffer in a
final volume of 25 ml. Amplification was performed in a GeneAmp PCR 9600
thermal cycler (Perkin-Elmer) with 45 consecutive cycles of 15 s at 948C, 15 s at
368C, and 70 s at 728C, with a single final extension step of 5 min at 728C. PCR
products were separated by electrophoresis in a 1.4% agarose gel and stained
with ethidium bromide. Patterns were visually interpreted by two independent
observers blinded to strain origin. Isolates showing patterns that differed by a
single band were considered minor variants of a given major type.
Statistical analysis. Difference in rates and proportions were tested by the
chi-square or Fisher exact test as appropriate (7).
RESULTS
Epidemiological investigation. During the study period, 54
of 1,088 (4.7%) isolates of K. pneumoniae produced detectable
ESBLs. The most frequent site of isolation was the respiratory
tract (38.2%), which was followed by deep fluids (20.5%), skin
and soft tissues (21.9%), and the urinary tract (19.1%). All
patients with bacteremia or with respiratory tract samples that
were positive for ESBL-producing K. pneumoniae were cared
for in the ICU. Forty-five patients harboring ESBL-producing
K. pneumoniae were identified, 19 (42.2%) of whom had stayed
in ICU; the incidence of isolation was 2.5 of 1,000 admissions
to the ICU versus 0.35 of 1,000 admissions to the other wards
(relative risk, 7.03; 95% confidence limits, 3.89 to 12.69; P ,
0.001).
During the study period, ESBL-producing strains from 7
(16%), 9 (20%), and 29 (64%) patients were considered im-
ported from other hospitals (positive culture ,48 h after hos-
pital admission), possibly imported (positive culture .48 h
after transfer from another hospital), and nosocomial (positive
culture .48 h after hospital admission without previous hos-
pital transfer), respectively. Among 19 patients in the ICU,
there were no imported cases, 4 cases were possibly imported,
and 15 cases were of nosocomial acquisition.
Nosocomial transmission in the ICU showed a progressive
decrease over time, since 10 cases were detected during 1990,
5 occurred in 1991, and no nosocomial case was apparent in
1992. In patients with nosocomial acquisition and possibly im-
ported or nosocomial acquisition, the time interval between
the date of admission and the date of first positive culture for
ESBL-producing K. pneumoniae ranged between 3 and 63 days
(median, 22 days).
Clinical data were recorded from 17 evaluable patients with
ESBL-producing K. pneumoniae in 1991 to 1992, 7 of whom
were cared for in the ICU. Infection occurred in 9 of 17
(52.9%) of these patients. The crude fatality rate was 11 of 45
(24.4%) patients with isolation of ESBL-positive strains.
Among clinically evaluable patients, death occurred in 1 of 8
colonized patients, compared with 5 deaths in 9 infected pa-
tients.
Use of extended-spectrum cephalosporins did not vary sub-
stantially during the study period. The yearly consumption of
ceftazidime, expressed in standard daily doses, was 2,200 in
1989, 2,417 in 1990, 2,167 in 1991, and 2,483 in 1992, while that
of ceftriaxone was approximately 1,000 in 1989, 750 in 1990,
850 in 1991, and 900 in 1992. During the 2-year evaluation
period of contact isolation precautions for patients with a pos-
itive culture for ESBL-producing K. pneumoniae, the rate of
nosocomial acquisition of this organism was 14 of 54,302 (0.26
per 1,000) admissions, compared with a rate of 15 of 27,038
(0.55 per 1,000) admissions during the year before introduction
of control measures (relative risk, 0.46; 95% confidence inter-
val, 0.22 to 0.96; P 5 0.03 [chi-square test]). Likewise, the
occurrence of clusters decreased from an initial rate of 1.85 per
1,000 admissions to 0.74 per 1,000 admissions (rate ratio, 0.40).
The distribution in time and place of patients positive for
ESBL-producing K. pneumoniae revealed the occurrence of
three clusters involving, respectively, seven, five, and five pa-
tients. The first cluster started in ICU no. 4 (five patients) and
continued, after transfer of the fifth patient, in ICU no. 2 (two
patients) over a 93-day period. The second cluster occurred 3
months after the first episode in ICU no. 4 (five patients) over
a 63-day period. The third cluster began 9 months later in ICU
no. 2 (two patients) and continued, after transfer of the second
patient, in ICU no. 4 (three patients) over a period of 55 days.
The other patients colonized with ESBL-producing K. pneu-
moniae isolates presented a sporadic occurrence.
Antimicrobial susceptibility. K. pneumoniae isolates from 19
patients from the ICU were distributed into four different
antibiotypes (Table 1). All strains exhibited a b-lactam suscep-
tibility profile consistent with the production of ESBL: (i) de-
creased susceptibility or resistance to amoxicillin, piperacillin,
cephalothin, cefamandole, extended-spectrum cephalosporins
and aztreonam; (ii) full susceptibility to imipenem, temocillin,
and cephamycins; and (iii) a positive disk synergy test with
extended-spectrum cephalosporins. The MICs of ceftazidime
(2 to 256 mg/ml) and ceftriaxone (12 to 24 mg/ml) showed a
reduction of more than fourfold in the presence of clavulanic
acid. The antibiotypes all shared resistance to sulfanomides,
trimethoprim, cotrimoxazole, and chloramphenicol. They were
distinguished by different susceptibilities to fluoroquinolones,
aminoglycosides, and tetracycline. Resistance to aminoglyco-
sides and fluoroquinolones was characteristic of two antibio-
types, but resistance to both was associated in only one (Table
1).
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Serotype. The strains were subdivided into six serotypes by K
antisera, of which five serotypes were found in multiple cases
(Table 1). Multiple serotypes were found to subdivide strains
with a given antibiotype.
Plasmid profiles. Three different plasmid profiles, each in-
cluding one to four plasmids with apparent molecular sizes
ranging from 2 to .70 kb, were found in the 18 strains ana-
lyzed (Table 1). The plasmid profiles were consistently associ-
ated with the antibiotype.
Genome macrorestriction analysis by PFGE. Chromosomal
DNA digested with XbaI produced an average of 20 fragments
ranging in size from less than 36 kb to approximately 700 kb
(Fig. 1). Four major groups of related macrorestriction
genomic patterns (A to D) were recognized, with 13 subclonal
variants distinguished by one to two fragment differences (Ta-
ble 1). The temporal distribution of episodes of colonization
among patients admitted to the ICU according to the classifi-
cation of isolates into major macrorestriction types showed the
occurrence of two consecutive clusters associated with clone A
and of one cluster associated with clone C (Fig. 2).
RAPD analysis. For each of the primers used, RAPD anal-
ysis yielded four groups of closely related fingerprints (major
types A through D), each exhibited by 12, 1, 5, and 1 strain(s),
respectively (Table 1). For group A, two subtypes obtained
with primer R108 and three subtypes obtained with primer
HLW74 were distinguished by single-band variations of the
core pattern. As shown in Fig. 3, primer HLW74 produced
four clearly different groups of fingerprints based on bands
with high intensity. Within group A, this primer allowed dis-
tinction of three variant fingerprints (Fig. 3, lanes 1, 2, and 3).
Besides several common bands, one subtype (a1) showed an
FIG. 1. PFGE separation of XbaI macrorestriction fragments of genomic
DNA of ESBL-producing K. pneumoniae isolates from ICU patients at Erasme
Hospital between 1990 and 1992. Four major genotypes are shown: type A (lanes
2 to 15), type B (lane 17), type C (lanes 18 to 23), and type D (lane 24). Lanes
1, 6, 11, 16, 21, and 25, molecular size markers (SmaI chromosomal digest of
S. aureus NCTC 8325).
FIG. 2. Temporal distribution of ESBL-producing K. pneumoniae isolation in
the ICU of Erasme Hospital, 1990 to 1992, according to major macrorestriction
types.
TABLE 1. Phenotypic and genomic markers of ESBL-producing K. pneumoniae strains from 19 patients
admitted to the Erasme hospital ICU
Strain Antibiotypea K sero-type
Plasmid
profile
Macro-
restriction
profile
RAPD pattern with
R108 AP4 HLWL74 Combined
1 ESBL/TETRA/CMP/SULF/TMP/SXT 6,19 1 A8 I1 1 a1 A1
2 ESBL/TETRA/CMP/SULF/TMP/SXT 6,19 1 A1 I1 1 a2 A2
3 ESBL/TETRA/CMP/SULF/TMP/SXT 6,19 1 A1 I1 1 a3 A3
4 ESBL/TETRA/CMP/SULF/TMP/SXT 19 1 A1 I1 1 a3 A3
5 ESBL/TETRA/CMP/SULF/TMP/SXT 6,19 1 A2 I1 1 a3 A3
6 ESBL/TETRA/CMP/SULF/TMP/SXT 6,19 1 A3 I1 1 a3 A3
7 ESBL/TETRA/CMP/SULF/TMP/SXT 19 1 A1 I1 1 a3 A3
8 ESBL/TETRA/CMP/SULF/TMP/SXT 4 1 A7 I2 1 a3 A5
9 ESBL/TETRA/CMP/SULF/TMP/SXT 4 1 A6 I2 1 a3 A5
10 ESBL/TETRA/CMP/SULF/TMP/SXT 4 1 A4 I2 1 a3 A5
11 ESBL/TETRA/CMP/SULF/TMP/SXT 4 1 A5 I1 1 a3 A3
12 ESBL/TETRA/CMP/SULF/TMP/SXT 4 1 A7 I2 1 a3 A5
13 ESBL/KTNA/CMP/SULF/TMP/SXT/PEF 25 2 B II 2 b B
14 ESBL/KTNA/CMP/SULF/TMP/SXT 7 3 C2 III 3 c C
15 ESBL/KTNA/CMP/SULF/TMP/SXT 7 3 C3 III 3 c C
16 ESBL/KTNA/CMP/SULF/TMP/SXT 7 3 C1 III 3 c C
17 ESBL/KTNA/CMP/SULF/TMP/SXT 10 3 C1 III 3 c C
18 ESBL/KTNA/CMP/SULF/TMP/SXT 7 3 C3 III 3 c C
19 ESBL/CMP/SULF/TMP/SXT/PEF 25 NDb D IV 4 d D
a Abbreviations: TETRA, tetracycline; CMP, chloramphenicol; SULF, sulfonamide; TMP, trimethoprim; SXT, cotrimoxazole; PEF, pefloxacin; K, kanamycin; T,
tobramycin; N, netilmicin; A, amikacin.
b ND, not determined.
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additional fragment of high intensity (approximate molecular
size of 0.7 kb) and the disappearance of a low-intensity frag-
ment with a size ,0.7 kb. For another subtype (a2), the mod-
ification consisted of an additional fragment of low intensity
with a molecular size of approximately 0.6 kb.
DISCUSSION
Plasmid-mediated ESBLs are found more frequently in K.
pneumoniae strains than in other Enterobacteriaceae species (8,
12, 13). Nosocomial outbreaks caused by ESBL-producing K.
pneumoniae have been reported in Europe and in the United
States (2, 4, 5, 8, 11, 14, 18–20). European surveys of nosoco-
mial isolates of K. pneumoniae show that approximately 15%
produce ESBLs (1). Infections caused by these strains, partic-
ularly in adult patients admitted to ICUs as observed in our
study, have been described elsewhere (2, 5, 14, 18). Coloniza-
tion of the gastrointestinal tract appears common in patients
hospitalized for prolonged periods (5). Selection pressure from
widespread hospital use of late-generation cephalosporins can
apparently be responsible for increasing occurrence of coloni-
zation of the digestive or respiratory tracts of patients (6). In
our hospital, small outbreaks occurred that were apparently
not associated with a significant increase in the use of extend-
ed-spectrum cephalosporins.
Since 1990, ESBL-producing K. pneumoniae isolates were
screened in our hospital by routine use of a synergy test with
disk diffusion susceptibility testing. Between 1990 and 1992,
5% of K. pneumoniae clinical isolates produced ESBLs, a rate
similar to that of a previous report from Belgium (25). With an
overall incidence of 0.6 cases per 1,000 admissions, isolation of
ESBL-producing strains was uncommon in this hospital pop-
ulation. Nevertheless, it was observed sevenfold more fre-
quently in patients admitted to ICU than in those admitted to
other units. In the ICU, 53% of the colonized patients devel-
oped an infection, further indicating that ESBL-producing K.
pneumoniae can be associated with significant morbidity in this
setting.
Space and time patterns of isolation suggest that the patients
hospitalized for long periods in the ICU acted as a reservoir for
cross-infection. This hypothesis was supported by the fact that
before contact precautions were introduced, epidemic strains
were responsible for several secondary cases, whereas only
sporadic cases were observed subsequently.
In this study, we compared the results of typing ESBL-
producing K. pneumoniae strains by a combination of pheno-
typic and genomic markers. Various antibiotic resistance pat-
terns were observed, including resistance to aminoglycosides
and fluoroquinolones. No modification in the resistance pat-
tern was noted for a given clone, as defined by the combined
typing results, during the course of infection and transmission.
Serotyping of capsular antigen displayed six serotypes. Al-
though this classical method is valued for its reproducibility
and stability, its usefulness was limited in some studies by a
high proportion of nontypeable strains (23). In our experience,
this method correlated poorly with molecular typing tech-
niques; isolates concordantly grouped in the same clone by all
genomic methods displayed as many as three distinct sero-
types, indicating antigenic instability.
Plasmid profile analysis has been widely used to differentiate
K. pneumoniae strains in epidemiological studies. This method
is of limited value because genetically unrelated strains may
harbor the same plasmids (2, 4) and related strains may lose
unstable plasmids (22, 23). In our study, all ESBL-producing K.
pneumoniae isolates tested had detectable plasmids, allowing
their classification into three different plasmid profiles that
were in agreement with clusters defined by chromosomal fin-
gerprints. Other workers also found good agreement between
plasmid profile and RAPD patterns of ESBL-producing K.
pneumoniae (9). Nevertheless, the epidemiology of nosocomial
outbreaks can be more complex when the spread of ESBL-
encoding plasmid occurs concomitantly with patient-to-patient
transmission of epidemic strains (4).
Macrorestriction polymorphisms resolved by PFGE clearly
delineated the genomic relatedness of ESBL-producing strains
of K. pneumoniae, as previously reported for this species (1, 11,
22). PFGE has been shown to be more discriminatory than
other genotypic techniques for typing Klebsiella species and
other bacteria (11, 15, 22, 24). PFGE analysis can detect chro-
mosomal rearrangements, even within closely related lineages.
The present study confirms the usefulness of this technique. K.
pneumoniae strains clustered into highly related groups, which
correlated well with epidemiological data, and further revealed
subtype variants displaying one to two fragment differences. K.
pneumoniae clones recovered during the course of the small
outbreaks examined here exhibited minor genomic differences,
as was found in studies of other bacterial species (15, 24). This
variability may reflect the genetic flexibility of bacterial patho-
gens in the hospital environment. On the other hand, PFGE
requires specialized equipment, costly reagents, and long DNA
preparation and electrophoresis times.
RAPD fingerprinting is another powerful typing method
(26) which has been used for studying the molecular epidemi-
ology of ESBL-producing K. pneumoniae strains in a previous
investigation (9) but had not previously been compared with
other high-resolution methods of genomic typing. The discrim-
inatory power of RAPD was good in the present study, since all
epidemiologically unrelated strains that were found markedly
different by PFGE also exhibited distinct RAPD types. Repro-
ducible patterns were obtained in independent experiments
(data not shown). RAPD and PFGE data showed complete
agreement in delineating closely related from less related iso-
lates, thereby further validating the reliability of PCR finger-
printing. However, PFGE with XbaI appeared more discrimi-
natory than the combined PCR fingerprints obtained with
three primers, since it identified more subclonal variants than
did RAPD analysis. Similar observations were made with other
gram-negative pathogens (15, 16, 24). For example, typing of
Legionella pneumophila by RAPD analysis with two 22-mer
primers showed good agreement with other genomic markers
while displaying a lower level of discrimination than PFGE of
genomic DNA digested with three infrequently cleaving endo-
nucleases (24). Likewise, RAPD analysis with two primers
showed a lower level of discrimination than macrorestriction
by two endonucleases for subtyping Pseudomonas aeruginosa
FIG. 3. RAPD fingerprinting of ESBL-producing K. pneumoniae. Four prin-
cipal RAPD fingerprints, a, b, c, and d (lanes 1 to 3, 4, 5, and 6, respectively) were
produced with primer HLWL74. Within fingerprint a, three subtypes, a1, a2, and
a3 (lanes 1, 2, and 3, respectively) were reproducibly distinguished. T, negative
control; M and M9, molecular size markers with fragment sizes indicated in
kilobases.
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strains from cystic fibrosis patients but provided complete
agreement with the latter method in delineating clonal groups
of strains (15).
The discriminatory ability of PFGE typing depends on the
number and type of restriction enzymes used, whereas that of
RAPD analysis is related to the number and type of primers
used, as well as PCR cycling parameters (15, 16, 24, 26). Thus,
extensive evaluation and selection of optimally discriminating
primer sets and PCR conditions can lead to RAPD schemes
that exhibit resolution superior to that of PFGE analysis, as
shown by typing Salmonella enteritidis (16). Discrepancies be-
tween the results of RAPD and PFGE typing might be ex-
plained by the fact that these methods explore different levels
of DNA polymorphism. PFGE is based on restriction fragment
length polymorphism and can resolve the whole chromosomal
DNA. In contrast, RAPD probes local sequence polymor-
phisms associated with repeat motifs occurring within genomic
DNA and also detects short-range length polymorphism of the
amplified segments.
In theory, plasmid DNA in whole-cell lysates may contribute
to particular RAPD patterns. Elaichouni et al. found no influ-
ence of plasmid DNA on the RAPD results in E. coli and
concluded that the excess amount of chromosomal DNA is
sufficient to inhibit observable amplification of plasmid DNA
(10). In our study, the correlations between plasmid profile and
RAPD patterns of K. pneumoniae isolates were 100, 90, and
75%, respectively, when typed with primer AP4, primer
HLW74, and primer R108, thereby suggesting a possible con-
tribution of plasmid DNA to the RAPD patterns. If this were
true, the inferior discriminatory power of RAPD compared
with that of PFGE could be related to amplification of plasmid
rather than chromosomal target DNA. Therefore, additional
studies should be performed with epidemiologically unrelated
isolates lacking ESBL-encoding plasmids before firm conclu-
sions can be drawn regarding the superior discrimination of
PFGE for typing K. pneumoniae.
Compared with PFGE, RAPD analysis is significantly sim-
pler to perform and produces results more rapidly. Typing was
done directly on genomic DNA released by a rapid heat lysis of
bacterial cells, without the need for any additional DNA ex-
traction or purification procedure. Therefore, RAPD typing is
more suitable for first-pass screening of related isolates during
investigation of outbreaks. Nevertheless, interassay reproduc-
ibility may be a problem with RAPD typing because of minor
variation in PCR reagents or cycling parameters (15). This was
not a problem in the present study, in which all isolates could
be processed within single assays.
In conclusion, although nosocomial acquisition of ESBL-
producing K. pneumoniae was uncommon in this hospital pop-
ulation, it was associated with significant morbidity in ICU
patients. In agreement with epidemiological data, the results of
PFGE and PCR typing indicated that several clones of ESBL-
producing K. pneumoniae were associated with either sporadic
infection or cross-infection. Both PFGE and RAPD analysis
appeared to be useful and discriminatory techniques for typing
ESBL-producing K. pneumoniae as a complement to antimi-
crobial susceptibility profiles. Although PFGE was more dis-
criminating, RAPD provided more efficient screening of
clonally related isolates. We recommend the use of RAPD
analysis as the initial method for delineating groups of close-
ly related isolates and the use of PFGE typing for confirma-
tion.
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